A Glimpse Into The Expert Outlook On Privia Health Gr Through 6 Analysts

6 analysts have expressed a variety of opinions on Privia Health Gr PRVA over the past quarter, offering a diverse set of opinions from bullish to bearish.

The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.

The 12-month price targets, analyzed by analysts, offer insights with an average target of $25.0, a high estimate of $28.00, and a low estimate of $21.00. This upward trend is evident, with the current average reflecting a 4.17% increase from the previous average price target of $24.00.

Investigating Analyst Ratings: An Elaborate Study

The standing of Privia Health Gr among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

• Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Privia Health Gr. This offers insight into analysts' perspectives on the current state of the company.
• Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Privia Health Gr compared to the broader market.
• Price Targets: Delving into movements, analysts provide estimates for the future value of Privia Health Gr's stock. This analysis reveals shifts in analysts' expectations over time.

Capture valuable insights into Privia Health Gr's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.

Stay up to date on Privia Health Gr analyst ratings.

About Privia Health Gr

Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.

Understanding the Numbers: Privia Health Gr's Finances

Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.

Revenue Growth: Privia Health Gr displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 4.95%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.

Net Margin: Privia Health Gr's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 0.81%, the company may face hurdles in effective cost management.

Return on Equity (ROE): Privia Health Gr's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 0.58%, the company may face hurdles in achieving optimal financial performance.

Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 0.32%, the company may need to address challenges in generating satisfactory returns from its assets.

Debt Management: Privia Health Gr's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.01.

Understanding the Relevance of Analyst Ratings

Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.

Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.

If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in Benzinga Pro.

Which Stocks Are Analysts Recommending Now?

Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.

This article was generated by Benzinga's automated content engine and reviewed by an editor.